Short-term quetiapine XR monotherapy effective for major depressive disorder
In utero valproate exposure linked to poorer cognitive outcomes at age 3
SIADH caused by multiple atypical antipsychotics
TMS vs. venlafaxine ER for treatment-resistant depression
Topiramate treatment in schizophrenia
PDAC conclusions
Variation in COMT associated with duloxetine response
Quetiapine XR patients with MDD
Atomoxetine for cognitive impairment in schizophrenia
Chest pain with prazosin for PTSD
From the FDA